Astragaloside IV ameliorates early diabetic nephropathy by inhibition of MEK1/2-ERK1/2-RSK2 signaling in streptozotocin-induced diabetic mice
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Objective: The aim of this study was to investigate the renoprotective effects and molecular mechanisms of astragaloside IV (AS-IV) in streptozotocin (STZ)-induced diabetic mice. Methods: Male C57BL/6 mice were injected intraperitoneally with STZ at 200 mg/kg body weight. AS-IV was administered for 8 consecutive weeks, beginning 1 week after STZ injection. Body weight, 24-hour urinary albumin excretion, and fasting blood glucose were measured. Kidney tissues were examined by histopathological analyses. Total levels and phosphorylation of mitogen-activated protein kinase 1/2 (MEK1/2), extracellular signal-regulated kinases 1 and 2 (ERK1/2), and ribosomal S6 kinase 2 (RSK2) were determined by Western blotting analysis. Results: AS-IV treatment significantly reduced albuminuria and serum creatinine levels, ameliorated mesangial matrix expansion and greater foot process width, and decreased the levels of urinary N-acetyl-beta-D-glucosaminidase, neutrophil gelatinase-associated lipocalin, and transforming growth factor-beta 1 in STZ-induced diabetic mice. AS-IV also inhibited renal cortical phosphorylation of MEK1/2, ERK1/2 and RSK2. Conclusion: Our results suggest that AS-IV attenuates renal injury in STZ-induced diabetic mice. This effect might be partially associated with inhibition of the activation of the MEK1/2-ERK1/2-RSK2 signaling pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, Astragaloside IV, a saponin purified from the Astragalus root, prevented DKD progression by stimulating autophagy in diabetic mice189-191”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [189]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calcium's Role in Mechanotransduction during Muscle Development
Benavides Damm, T., & Egli, M. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000356667 · Cited by 14,502
Seger, R., & Krebs, E. G. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.9.7601337 · Cited by 3,602
KDOQI clinical practice guideline for diabetes and CKD: 2012 update
(2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.07.005 · Cited by 1,320
Cobb, M. H. (1999) · Progress in Biophysics and Molecular Biology · doi:10.1016/s0079-6107(98)00056-x · Cited by 875
End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions
Ritz, E., Rychlík, I., Locatelli, F., & Halimi, S. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70035-1 · Cited by 806
Pathogenesis, prevention, and treatment of diabetic nephropathy
Cooper, M. E. (1998) · The Lancet · doi:10.1016/s0140-6736(98)01346-4 · Cited by 560
Glomerular cell number in normal subjects and in type 1 diabetic patients
Steffes, M. W., Schmidt, D., Mccrery, R., & Basgen, J. M. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00725.x · Cited by 408
Chen, L., Yang, T., Lu, D.-W., Zhao, H., Feng, Y.-L., Chen, H., Chen, D.-Q., Vaziri, N. D., & Zhao, Y.-Y. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.02.090 · Cited by 359
Diabetic Nephropathy and Extracellular Matrix
Kolset, S. O., Reinholt, F. P., & Jenssen, T. (2012) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155412465073 · Cited by 291
Cellular and Molecular Mechanisms of Proteinuria in Diabetic Nephropathy
Wolf, G., & Ziyadeh, F. N. (2007) · Nephron Physiology · doi:10.1159/000101797 · Cited by 264
Cited by
Autophagy in kidney homeostasis and disease
Tang, C., Livingston, M. J., Liu, Z., & Dong, Z. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0309-2 · Cited by 496
(2020) · Advances in Pharmacology · doi:10.1016/bs.apha.2019.08.002 · Cited by 430
Pharmacological Effects of Astragaloside IV: A Review
Liang, Y., Chen, B., Liang, D., Quan, X., Gu, R., Meng, Z., Gan, H., Wu, Z., Sun, Y., Liu, S., et al. (2023) · Molecules · doi:10.3390/molecules28166118 · Cited by 200
A natural products solution to diabetic nephropathy therapy
Hu, Q., Jiang, L., Qi, Y., Zeng, J., Ma, X., & Zhao, Y. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108314 · Cited by 150
Herbal Medicine for Slowing Aging and Aging-associated Conditions: Efficacy, Mechanisms and Safety
Hoa, P. T., Thuan, D. T. B., Nguyen, T. H. D., Posadino, A. M., Eid, A. H., & Pintus, G. (2019) · Current Vascular Pharmacology · doi:10.2174/1570161117666190715121939 · Cited by 114
Metadata
- Authors
- Song, G., Han, P., Sun, H., Shao, M., Yu, X., Wang, W., Wang, D., Yi, W., Ge, N., Li, S., & Yi, T.
- Affiliations
- Guangzhou University of Chinese Medicine (CN)
- Corresponding author
- Yi, Tiegang
- ORCID
- Venue
- Journal of International Medical Research
- Publisher
- SAGE Publications
- Published
- 2018-06-13
- Volume
- 46
- Issue
- 7
- Pages
- 2883-2897
- ISSN
- 0300-0605 (ISSN-L)
- 1473-2300
- PMC
- PMC6124299
- OpenAlex
- W2808372909
- Cited by
- 34
- References
- 52
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 4 · 2023: 6 · 2022: 2 · 2021: 5 · 2020: 5 · 2019: 6
- FWCI
- 3.27
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of International Medical Research (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (81373565, 81673794)
- Natural Science Foundation of Guangdong Province (2015A030313883)
- Shenzhen Science and Technology Project (JCYJ20150401163247228, JCYJ20160330171116798)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Health Sciences › Medicine › Complementary and alternative medicine › Traditional Chinese Medicine Analysis
- Keywords
- astragaloside IV, diabetic nephropathy, renal protection, streptozotocin-induced diabetes, albuminuria, mesangial expansion, neutrophil gelatinase-associated lipocalin, TGF-β1, MAPK signaling
- MeSH terms
- Animals, Diabetes Mellitus, Experimental, Diabetic Nephropathies, Drugs, Chinese Herbal, Kidney, Male, Mice, Inbred C57BL, Saponins, Triterpenes, Protective Agents, MAP Kinase Signaling System, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Astragaloside IV ameliorates early diabetic nephropathy by inhibition of MEK1/2-ERK1/2-RSK2 signaling in streptozotocin-induced diabetic mice. https://app.cochat.ai/papers/10.1177/0300060518778711
- The paper
- Song, G., Han, P., Sun, H., Shao, M., Yu, X., Wang, W., Wang, D., Yi, W., Ge, N., Li, S., & Yi, T. (2018). Astragaloside IV ameliorates early diabetic nephropathy by inhibition of MEK1/2-ERK1/2-RSK2 signaling in streptozotocin-induced diabetic mice. Journal of International Medical Research. https://doi.org/10.1177/0300060518778711
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.